(Q34521591)

2 August 2017

1 reference

title

Health-related quality of life in patients treated for hypertension: a review of the literature from 1990 to 2000. (English)

1 reference

2 August 2017

1 reference

Karin S Coyne

1

1 reference

2 August 2017

Darlene Davis

series ordinal

2

1 reference

2 August 2017

Feride Frech

series ordinal

3

1 reference

2 August 2017

Martha N Hill

series ordinal

4

1 reference

2 August 2017

publication date

1 January 2002

1 reference

2 August 2017

published in

Clinical Therapeutics

1 reference

2 August 2017

volume

24

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

142-169

1 reference

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

The effects of antihypertensive therapy on the quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life in treatment of hypertension. A metaanalysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Recommendations for evaluating the validity of quality of life claims for labeling and promotion

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: field trial in general practice. The OCAPI Study Group. Optimiser le Choix d'un Anti-hypert

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

The Impact of Diuretic Therapy on Reported Sexual Function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Effects of antihypertensive medications on quality of life in elderly hypertensive women.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. LOA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life comparison between bisoprolol and nifedipine retard in hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life in hypertensive patients treated with either carvedilol or enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

A comparison of verapamil and nifedipine on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life in hypertensives treated with atenolol or captopril: a double-blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blocker.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Effect of antihypertensives on sexual function and quality of life: the TAIM Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Changes in physical symptoms, blood pressure and quality of life over 30 days.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

Quality-of-life measures in the evaluation of antihypertensive drug therapy: reliability, validity, and quality-of-life domains.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985012-3

7 January 2021

10.1016/S0149-2918(02)85012-3

Identifiers

DOI

1 reference

2 August 2017

1 reference